Skip to main content

Want a detailed portfolio tracker?

Chimerix (CMRX) P/E (2013 - 2026)

Chimerix (CMRX) P/E from Jul 1, 2013 to Jul 21, 2026. The TTM Chimerix (CMRX) P/E is -8.66. You can export chart.

P/E

Annual P/E change of Chimerix (CMRX)

YearP/EChange
2026-8.66N/A
2025-8.66+145.40%
2024-3.53+251.27%
2023-1.00-193.42%
20221.07-135.11%
2021-3.06-55.56%
2020-6.89+1253.53%
2019-0.51+4.25%
2018-0.49-44.88%
2017-0.89-43.14%
2016-1.56-53.08%
2015-3.32-84.64%
2014-21.60+74.80%
2013-12.36N/A

Comparison Chimerix (CMRX) P/E with competitors

Chimerix (CMRX) P/E is -8.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.86%
FGENFibroGen Inc0.24-102.77%
CHRSCoherus Biosciences Inc0.85-109.80%
FBIOFortress Biotech Inc0.95-110.96%
ORMPOramed Pharmaceuticals Inc1.50-117.36%
AGENAgenus Inc3.01-134.77%
INVAInnoviva Inc3.15-136.44%
VXRTVaxart Inc3.55-141.01%
CRMDCorMedix Inc3.63-141.92%
CVACCureVac N.V.4.45-151.36%
GLPGGalapagos NV4.86-156.13%
SRPTSarepta Therapeutics Inc4.88-156.40%
ABEOAbeona Therapeutics Inc5.39-162.24%
ABUSArbutus Biopharma Corp5.60-164.65%
ZVRAZevra Therapeutics Inc5.89-168.02%
SPROSpero Therapeutics Inc6.23-171.96%
CGENCompugen Ltd6.31-172.95%
RIGLRigel Pharmaceuticals6.87-179.39%
SLXNSilexion Therapeutics Corp7.30-184.29%
OMEROmeros Corporation9.26-206.97%
AUPHAurinia Pharmaceuticals Inc9.58-210.74%
PLXProtalix BioTherapeutics Inc10.89-225.82%
ACADAcadia Pharmaceuticals Inc11.73-235.50%
TBPHTheravance Biopharma Inc12.26-241.67%
ADMAAdma Biologics Inc12.42-243.47%
HRMYHarmony Biosciences Holdings Inc13.82-259.67%
SABSSAB Biotherapeutics Inc14.14-263.32%
NAGENiagen Bioscience Inc14.82-271.19%
INCYIncyte Corp15.82-282.80%
REGNRegeneron Pharmaceuticals Inc15.86-283.19%
PBYIPuma Biotechnology Inc17.32-300.05%
CPRXCatalyst Pharmaceuticals Inc17.44-301.48%
EXELExelixis Inc17.54-302.62%
TGTXTG Therapeutics Inc18.97-319.12%
MDXGMimedx Group Inc20.55-337.44%
XOMAXOMA Royalty Corp22.87-364.28%
ARGXArgen X SE24.30-380.72%
CTMXCytomX Therapeutics Inc24.82-386.77%
XOMAOXOMA Royalty Corp25.34-392.82%
HALOHalozyme Therapeutics Inc25.62-396.04%
XOMAPXOMA Royalty Corp25.67-396.58%
VRTXVertex Pharmaceuticals Inc27.99-423.43%
RPRXRoyalty Pharma plc - Class A28.69-431.44%
SLNOSoleno Therapeutics Inc29.02-435.22%
ASNDAscendis Pharma A/S30.09-447.59%
LGNDLigand Pharmaceuticals Inc - Class B37.91-538.01%
APLSApellis Pharmaceuticals Inc39.02-550.83%
BMRNBiomarin Pharmaceutical Inc42.21-587.69%
KRYSKrystal Biotech Inc45.34-623.87%
ONCBeiGene Ltd69.54-903.43%
PHARPharming Group N.V.75.03-966.80%
TECHBio-Techne Corp101.96-1277.96%
VCELVericel Corp109.92-1369.96%
ALNYAlnylam Pharmaceuticals Inc117.96-1462.89%
GMABGenmab140.29-1720.83%
TLXTelix Pharmaceuticals Ltd162.15-1973.41%
CORTCorcept Therapeutics Inc212.86-2559.22%